Intestinal fluid secretion pathway

"Intestinal fluid secretion pathway" is not a single molecule, receptor, or canonical therapeutic target; rather, it refers to a coordinated set of mechanisms in intestinal epithelial cells that regulate the secretion of water and electrolytes—especially via chloride-driven secretory processes. The pathway's principal molecular players include the cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel (an ATP-binding cassette transporter family member), basolateral Na⁺/K⁺-ATPase, NKCC1 cotransporter, apical chloride channels, various potassium channels, calcium-activated chloride channels, hormone and neurotransmitter receptors, and exchange transporters[1][2][3]. Chloride secretion establishes the primary osmotic gradient driving water influx into the intestinal lumen[6]. The process is tightly regulated by cAMP- and Ca²⁺-dependent signaling through both neural and immune mediators. Dysregulation of any component can result in disease, such as secretory diarrhea (over-secretion) or constipation (under-secretion). Pharmacologic modulation of specific proteins within these pathways (not the abstract "pathway" itself) forms the basis of multiple classes of drugs for both diarrheal and constipating disorders[1][2]. Thus, "intestinal fluid secretion pathway" is a valid physiological process, but not a molecular target, receptor, or single therapeutic entity. "Intestinal fluid secretion pathways" is not a single canonical target, nor does it have a standard abbreviation, and the term itself does not refer to one protein, enzyme, receptor, or drug target, but rather a network of physiological and molecular processes[1][2][3]. For drug targeting, components like "cystic fibrosis transmembrane conductance regulator (CFTR)," "sodium-potassium-chloride cotransporter 1 (NKCC1)," or "calcium-activated chloride channel" are more precise canonical targets.

Activation or inhibition of chloride channels (e.g., CFTR agonists or antagonists); Stimulation of cAMP or Ca²⁺ signaling in epithelial cells; Modulation of specific ion transporters (e.g., NKCC1, Na⁺/K⁺-ATPase); Indirect modulation by neurohormones, immune mediators, and microbial products